ruxolitinib
Showing 1 - 25 of 146
Ruxolitinib in Patients With Myelofibrosis
Completed
- Myelofibrosis
- Ruxolitinib
- (no location specified)
Jun 5, 2022
Necrobiosis Lipoidica Trial in Scottsdale (Ruxolitinib)
Completed
- Necrobiosis Lipoidica
- Ruxolitinib
-
Scottsdale, ArizonaMayo Clinic in Arizona
Mar 17, 2022
Myelofibrosis Trial in Jinan (Ruxolitinib)
Recruiting
- Myelofibrosis
- Ruxolitinib
-
Jinan, Shandong, ChinaQilu Hospital of Shandong University
Jul 3, 2022
Chronic Hand Dermatitis Trial in Rochester (Ruxolitinib)
Recruiting
- Chronic Hand Dermatitis
- Ruxolitinib
-
Rochester, New YorkUR Medicine Dermatology College Town
Aug 9, 2022
Steroid Refractory GVHD Trial in Taoyuan (Ruxolitinib)
Completed
- Steroid Refractory GVHD
- Ruxolitinib
-
Taoyuan, TaiwanChang Gung Memorial Hospital
Dec 15, 2022
Discoid Lupus Erythematosus Trial in Rochester (Ruxolitinib)
Enrolling by invitation
- Discoid Lupus Erythematosus
- Ruxolitinib
-
Rochester, New YorkUR Medicine Dermatology College Town
May 20, 2022
Polycythemia Vera Trial (Ruxolitinib)
Available
- Polycythemia Vera
- Ruxolitinib
- (no location specified)
Mar 7, 2022
Hematopoietic Stem Cell Transplant (HSCT), Bronchiolitis Obliterans (BO) Trial in Cincinnati (Ruxolitinib)
Recruiting
- Hematopoietic Stem Cell Transplant (HSCT)
- Bronchiolitis Obliterans (BO)
- Ruxolitinib
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Aug 6, 2022
T-Cell Large Granular Lymphocyte Leukemia Trial in Columbus (Ruxolitinib)
Not yet recruiting
- T-Cell Large Granular Lymphocyte Leukemia
- Ruxolitinib
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Oct 20, 2022
Macrophage Activation Syndrome Trial (Ruxolitinib, methylprednisolone)
Not yet recruiting
- Macrophage Activation Syndrome
- Ruxolitinib
- methylprednisolone
- (no location specified)
Mar 16, 2022
Myelofibrosis Trial in Houston (Long-term Follow-up, Quality-of-Life Assessment, Ruxolitinib)
Active, not recruiting
- Myelofibrosis
- Long-term Follow-up
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jul 9, 2022
T Cell Leukemia, Adult, Leukemia, Adult T-Cell, T Cell Leukemia, HTLV I Associated Trial run by the NCI (Ruxolitinib,
Completed
- T Cell Leukemia, Adult
- +2 more
- Ruxolitinib
- ruxolitinib
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 26, 2022
Hematopoietic and Lymphoid Cell Tumor, Steroid Refractory GVHD Trial in Houston (Cellular Therapy, Ruxolitinib)
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Steroid Refractory Graft Versus Host Disease
- Cellular Therapy
- Ruxolitinib
-
Houston, TexasM D Anderson Cancer Center
Jul 9, 2022
Myelofibroses Trial in Saint Louis (Pevonedistat, Ruxolitinib, Peripheral blood draw)
Terminated
- Myelofibroses
- Pevonedistat
- +3 more
-
Saint Louis, MissouriWashington University School of Medicine
Dec 16, 2021
Graft-versus-host Disease Trial in Milwaukee (Cyclophosphamide, Tacrolimus, Mycophenolate Mofetil)
Not yet recruiting
- Graft-versus-host Disease
- Cyclophosphamide
- +3 more
-
Milwaukee, WisconsinFroedtert Hospital & the Medical College of Wisconsin
Jan 26, 2023
Myelofibrosis Trial in Saint Louis (Fostamatinib, Ruxolitinib)
Recruiting
- Myelofibrosis
- Fostamatinib
- Ruxolitinib
-
Saint Louis, MissouriWashington University School of Medicine
May 6, 2022
Bronchiolitis Obliterans Syndrome, Hematologic Malignancy Trial in Hangzhou (Ruxolitinib)
Not yet recruiting
- Bronchiolitis Obliterans Syndrome
- Hematologic Malignancy
- Ruxolitinib
-
Hangzhou, Zhejiang, ChinaThe first Affiliated Hospital of Zhejiang University
Jun 7, 2022
COVID-19 Trial (Ruxolitinib)
No longer available
- COVID-19
- Ruxolitinib
- (no location specified)
Dec 1, 2021
QoL and Symptoms in Polycythemia Vera Receiving Ruxo inRoutine
Not yet recruiting
- Polycythemia Vera
- Ruxolitinib
- (no location specified)
Sep 30, 2022
Primary Myelofibrosis (PMF), Post Polycythemia Myelofibrosis (PPV MF), Thrombocythemia Myelofibrosis (PET-MF) Trial
Available
- Primary Myelofibrosis (PMF)
- +2 more
- Ruxolitinib
- (no location specified)
Jan 18, 2022
Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (Apeced), Alopecia Areata Trial run by the National Institute of
Recruiting
- Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (Apeced)
- Alopecia Areata
- Ruxolitinib
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 17, 2022
Myelofibrosis, Polycythemia Vera Trial in United States (TGR-1202, ruxolitinib)
Active, not recruiting
- Myelofibrosis
- Polycythemia Vera
- TGR-1202
- ruxolitinib
-
Phoenix, Arizona
- +4 more
Jun 20, 2022
Graft-versus-host-disease, Stem Cell Transplant Complications, Acute Myeloid Leukemia Trial in Moscow, Saint Petersburg
Recruiting
- Graft-versus-host-disease
- +3 more
- Ruxolitinib
- +2 more
-
Moscow, Russian Federation
- +1 more
Apr 4, 2022